Ozuriftamab vedotin
Ozuriftamab vedotin (BA3021), an antibody-drug conjugate (ADC), is a conditionally active biologic (CAB) anti-receptor tyrosine kinase orphan receptor 2 (ROR2) humanized monoclonal antibody Ozuriftamab (HY-145626) conjugated to VcMMAE (HY-15575) . Ozuriftamab vedotin has antitumor activities[1].
Product Specifications
Product Name Alternative
BA3021; Anti-ROR2 ADC; CAB-ROR2-ADC
UNSPSC
12352211
Target
Antibody-Drug Conjugates (ADCs) ; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ozuriftamab-vedotin.html
Purity
99.65
Smiles
[Ozuriftamabvedotin]
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145627/Ozuriftamab-vedotin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145627/Ozuriftamab-vedotin-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 2
CAS Number
[2460400-11-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse Zfp775 shRNA (UAS) - Lentiviral mouse Zfp775 shRNA (UAS, RFP) plasmid
BPI, ID (BPI, Bactericidal permeability-increasing protein, CAP 57) (MaxLight 490)
BPI, ID (BPI, Bactericidal permeability-increasing protein, CAP 57) (MaxLight 490)
Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) RUD3 Polyclonal Antibody
